000 01282 a2200325 4500
005 20250517193748.0
264 0 _c20180907
008 201809s 0 0 eng d
022 _a2299-5684
024 7 _a10.1016/j.pharep.2017.07.011
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaciak, Przemysław Paweł
245 0 0 _aDrugs which influence serotonin transporter and serotonergic receptors: Pharmacological and clinical properties in the treatment of depression.
_h[electronic resource]
260 _bPharmacological reports : PR
_cFeb 2018
300 _a37-46 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAffect
_xdrug effects
650 0 4 _aAnimals
650 0 4 _aAntidepressive Agents
_xadverse effects
650 0 4 _aBrain
_xdrug effects
650 0 4 _aDepressive Disorder, Major
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aSerotonin Antagonists
_xadverse effects
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xadverse effects
650 0 4 _aTreatment Outcome
700 1 _aLysenko, Natalia
700 1 _aMazurek, Aleksander Paweł
773 0 _tPharmacological reports : PR
_gvol. 70
_gno. 1
_gp. 37-46
856 4 0 _uhttps://doi.org/10.1016/j.pharep.2017.07.011
_zAvailable from publisher's website
999 _c27956716
_d27956716